Bigul

Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for INTIMATION OF '3/2018-19' BOARD MEETING

JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Reg., 2015, please be informed that Meeting of Board of Directors of the Company will be held on Wed., the 13th Day of Feb., 2019 at its registered office at 12:00 P.M., inter-alia, to consider and approve the following business: 1. consider and approve the Standalone Un-Audited Financial Results of the Company for the quarter ended 31st December 2018, pursuant to Regulation 33 of SEBI (LODR), Reg. 2015; 2. consider and take note of Limited Review Report of Statutory Auditor on Standalone Un-Audited Financial Results of the Company for the quarter ended 31st December 2018; Further, in accordance with the company''s code of conduct for prevention of Insider Trading as per Regulation 9 of SEBI (PIT) Reg., 2015, the trading window for all the directors or designated employees or connected persons or their immediate relatives will remain closed from Monday, the 4th Feb., 2019 to Friday, 15 Feb., 2019 (Both days inclusive).
04-02-2019
Bigul

Jagsonpal Pharmaceuticals Ltd - 507789 - Statement Of Investor Complaints For The Quarter Ended December 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0880 Name of the Signatory :- R K KAPOORDesignation :- Company Secretary and Compliance Officer
10-01-2019
Bigul

Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholding for the Period Ended December 31, 2018

Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
10-01-2019
Bigul

Outcome of Board Meeting

Outcome of the meeting of the Board of Directors held on 14.11.2018
14-11-2018
Bigul

Results Quarter And Half Year Ended 30.09.2018

Results Quarter and Half year ended 30.09.2018
14-11-2018
Bigul

Board Meeting Intimation for SUBJECT : NOTICE FOR BOARD MEETING TO CONSIDER UN-AUDITED FINANCIAL RESULTS FOR THE 2Nd QUARTER / HALF YEAR 30.09.2018

JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve Sir, Pursuant to Regulation 29 read with Regulation 47 of the SEBI Listing Obligation and Disclosure Requirements Regulation, 2015, we hereby give notice that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 14/11/2018. inter-alia,...
05-11-2018
Bigul

Board Meeting Intimation for SUBJECT : NOTICE FOR BOARD MEETING TO CONSIDER UN-AUDITED FINANCIAL RESULTS FOR THE 2Nd QUARTER / HALF YEAR 30.09.2018

JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve Sir, Pursuant to Regulation 29 read with Regulation 47 of the SEBI Listing Obligation and Disclosure Requirements Regulation, 2015, we hereby give notice that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 14/11/2018. inter-alia,...
05-11-2018
Bigul

SUBJECT : CERTIFICATE UNDER REGULATION 40 (9) OF LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENT) REGULATIONS, 2015.

Sir/Madam, In terms of regulation 40 (9) of Listing Obligations And Disclosure Requirement Regulations 2015, we are enclosing herewith Certificate dated 15/10/2018 certified by Mukesh Arora & Co., Practicing Company Secretary for the half year ended 30th September, 2018 for your records. This is for your information & records pursuant to Regulation 40 (10) of SEBI LODR 2015. Thanking you,
17-10-2018
Bigul

Shareholding for the Period Ended September 30, 2018

Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here
16-10-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended September 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 012120 Name of the Signatory :- R K KAPOORDesignation :- Company Secretary and Compliance Officer
12-10-2018
Next Page
Close

Let's Open Free Demat Account